Total Payments
$3,101
2024 Payments
$1,323
Companies
41
Transactions
135
Medicare Patients
5,739
Medicare Billing
$593,112
Payment Breakdown by Category
Food & Beverage$3,101 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,101 | 135 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $748.91 | 26 | $0 (2024) |
| Astellas Pharma US Inc | $546.93 | 29 | $0 (2024) |
| PROCEPT BioRobotics Corporation | $176.46 | 2 | $0 (2024) |
| COLOPLAST CORP | $172.21 | 6 | $0 (2024) |
| PFIZER INC. | $171.83 | 9 | $0 (2024) |
| IMMUNITYBIO, INC. | $152.53 | 1 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $129.15 | 7 | $0 (2024) |
| Mallinckrodt Enterprises LLC | $84.59 | 6 | $0 (2019) |
| Endo USA, Inc. | $64.98 | 3 | $0 (2024) |
| Davol Inc. | $64.03 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,323 | 47 | Janssen Biotech, Inc. ($292.63) |
| 2023 | $281.87 | 14 | Janssen Biotech, Inc. ($66.23) |
| 2022 | $332.67 | 12 | Janssen Biotech, Inc. ($161.25) |
| 2021 | $100.50 | 6 | Astellas Pharma US Inc ($42.14) |
| 2020 | $33.41 | 2 | Astellas Pharma US Inc ($18.55) |
| 2019 | $391.16 | 17 | Janssen Biotech, Inc. ($189.84) |
| 2018 | $370.65 | 22 | Astellas Pharma US Inc ($173.35) |
| 2017 | $267.32 | 15 | Astellas Pharma US Inc ($132.34) |
All Payment Transactions
135 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: ONCOLOGY | ||||||
| 12/12/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $26.46 | General |
| Category: Oncology | ||||||
| 12/12/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $0.82 | General |
| Category: Oncology | ||||||
| 12/10/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 11/20/2024 | IMMUNITYBIO, INC. | ANKTIVA (Drug) | Food and Beverage | In-kind items and services | $152.53 | General |
| Category: Immunotherapy | ||||||
| 11/14/2024 | PFIZER INC. | XTANDI (Drug), TALZENNA | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: ONCOLOGY | ||||||
| 11/12/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $28.44 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 10/31/2024 | STERIS CORPORATION | Uretero1 (Device) | Food and Beverage | In-kind items and services | $32.90 | General |
| Category: Devices | ||||||
| 10/17/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: Oncology | ||||||
| 10/15/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $20.61 | General |
| Category: Oncology | ||||||
| 10/10/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: UROLOGY | ||||||
| 10/03/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $15.99 | General |
| Category: ONCOLOGY | ||||||
| 10/02/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Oncology | ||||||
| 10/01/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: UROLOGY | ||||||
| 09/26/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $26.44 | General |
| Category: Oncology | ||||||
| 09/25/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: HORMONE THERAPY | ||||||
| 09/24/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 09/10/2024 | COLOPLAST CORP | Saffron (Device) | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: Devices | ||||||
| 09/03/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: ONCOLOGY | ||||||
| 08/29/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $21.44 | General |
| Category: Oncology | ||||||
| 08/20/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $30.58 | General |
| Category: Oncology | ||||||
| 08/15/2024 | Endo USA, Inc. | AVEED (Biological) | Food and Beverage | In-kind items and services | $22.18 | General |
| Category: UROLOGY | ||||||
| 08/06/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: Oncology | ||||||
| 07/29/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: ONCOLOGY | ||||||
| 07/25/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $23.92 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 29 | 1,837 | 2,928 | $481,117 | $198,332 |
| 2022 | 20 | 1,339 | 1,969 | $581,682 | $130,744 |
| 2021 | 24 | 1,386 | 3,630 | $857,714 | $152,801 |
| 2020 | 19 | 1,177 | 1,728 | $577,421 | $111,235 |
Total Patients
5,739
Total Services
10,255
Medicare Billing
$593,112
Procedure Codes
92
All Medicare Procedures & Services
92 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 399 | 783 | $160,515 | $91,349 | 56.9% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 17 | 153 | $74,664 | $20,988 | 28.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 166 | 188 | $28,894 | $16,983 | 58.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 120 | 120 | $35,093 | $16,857 | 48.0% |
| 52005 | Insertion of tube into ureter using an endoscope through bladder area | Facility | 2023 | 93 | 109 | $54,064 | $8,741 | 16.2% |
| 99487 | Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 15 | 55 | $7,150 | $5,180 | 72.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 34 | 36 | $10,512 | $4,076 | 38.8% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 29 | 41 | $17,000 | $3,932 | 23.1% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 22 | 81 | $5,670 | $3,681 | 64.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 23 | 36 | $5,436 | $3,139 | 57.7% |
| 74178 | Ct scan of abdomen and pelvis before and after contrast | Office | 2023 | 37 | 38 | $8,996 | $2,710 | 30.1% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 396 | 678 | $9,492 | $2,626 | 27.7% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 14 | 14 | $4,872 | $2,400 | 49.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 23 | 23 | $5,336 | $2,080 | 39.0% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Office | 2023 | 32 | 34 | $6,824 | $1,969 | 28.9% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 47 | 49 | $9,000 | $1,800 | 20.0% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Office | 2023 | 24 | 24 | $4,840 | $1,655 | 34.2% |
| 52204 | Biopsy of bladder using an endoscope | Facility | 2023 | 17 | 18 | $10,980 | $1,599 | 14.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 25 | 25 | $2,575 | $1,530 | 59.4% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 14 | 15 | $4,320 | $1,424 | 33.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 108 | 168 | $1,011 | $877.94 | 86.8% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 14 | 15 | $3,975 | $625.65 | 15.7% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 16 | 25 | $1,375 | $585.75 | 42.6% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 54 | 62 | $2,666 | $443.92 | 16.7% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 22 | 24 | $912.00 | $432.48 | 47.4% |
About Dr. Mark Lyell, MD
Dr. Mark Lyell, MD is a Urology healthcare provider based in Ocean Springs, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1407861776.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Lyell, MD has received a total of $3,101 in payments from pharmaceutical and medical device companies, with $1,323 received in 2024. These payments were reported across 135 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($3,101).
As a Medicare-enrolled provider, Lyell has provided services to 5,739 Medicare beneficiaries, totaling 10,255 services with total Medicare billing of $593,112. Data is available for 4 years (2020–2023), covering 92 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Ocean Springs, MS
- Active Since 07/29/2006
- Last Updated 05/22/2025
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1407861776
Products in Payments
- ERLEADA (Drug) $520.11
- MYRBETRIQ (Drug) $273.88
- Erleada (Drug) $215.94
- XTANDI (Drug) $195.08
- AQUABEAM SYSTEM (Device) $176.46
- ANKTIVA (Drug) $152.53
- Xtandi (Drug) $122.54
- Myrbetriq (Drug) $115.73
- OFIRMEV (Drug) $84.59
- XIAFLEX (Biological) $84.39
- GEMTESA (Drug) $81.68
- ELIGARD (Drug) $64.51
- ORGOVYX (Drug) $61.66
- TITAN (Device) $56.17
- JELMYTO (Drug) $49.02
- PENILE & TESTICULAR RECONSTRUCTN (Device) $48.09
- AVEED (Biological) $43.64
- Noctiva (Drug) $42.90
- PROLARIS (Device) $39.88
- INTERSTIM (Device) $38.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Ocean Springs
Dr. David Spencer, M.d, M.D
Urology — Payments: $3,926
Urology $3,926
Dr. David Owens, M.d, M.D
Urology — Payments: $3,640
Urology $3,640
Dr. Guy Shoaf, M.d, M.D
Urology — Payments: $2,609
Urology $2,609
Dr. Ian Coate, Md, MD
Urology — Payments: $2,456
Urology $2,456
Dr. Francis Selman, Md, MD
Urology
Urology